The Science of Reliability: Our Dual-Layered Quality Framework
In the specialized field of peptide therapy, clinical outcomes are directly tied to the scientific rigor behind the manufacturing process. For medical institutions and providers utilizing private label peptide services, understanding the testing protocols behind the products is paramount.
As a premier 503B outsourcing facility, MayMag Biologics (formerly Zeptide Pharma) operates under a rigorous, dual-layered Quality Control (QC) and Quality Assurance (QA) framework. We surpass standard cGMP mandates by integrating advanced analytical verification into every phase of production, ensuring that every vial of human-use peptides meets the gold standard of pharmaceutical excellence.
Comprehensive Testing Protocols
1. Stringent Incoming Material Verification Quality control begins before materials enter the cleanroom. We independently verify all raw materials rather than relying solely on vendor documentation.
- Identity Testing: We utilize FTIR spectroscopy, Raman spectroscopy, and HPLC to chemically verify that every Active Pharmaceutical Ingredient (API) matches its label exactly.
- Purity and Potency: All APIs are screened for moisture content, heavy metals, and residual solvents to ensure strict compliance with USP monographs.
- Component Inspection: Vials, stoppers, and seals undergo rigorous visual and physical testing to eliminate defects or bioburden prior to bulk manufacturing.
2. Real-Time In-Process Testing Precision is maintained through continuous monitoring during the compounding process.
- Filling Accuracy: Routine checks on all lines guarantee dispensing accuracy (e.g., verifying a precise 10.5mL fill for a 10mL vial).
- Physiological Stabilization: For IV solutions, pH and osmolality are tested mid-batch to ensure product stability and patient comfort.
- Visual Vigilance: Continuous monitoring during the filling stage ensures no particulate matter or glass defects are present.
3. Advanced Finished Product Analytical Testing No clinical-grade peptide is released without comprehensive post-production verification.
- Potency Assay (HPLC): We use High-Performance Liquid Chromatography to confirm every drug meets its exact intended strength, strictly within the narrow 90% to 110% range.
- Purity Profiling: Formulations are screened for any degradation products or related substances that may have formed during compounding.
- Particulate Matter Analysis (USP <788>): Light-obscuration methods guarantee that all sterile injectable peptides are free of dust, plastic, or glass particles.
4. Comprehensive Microbiological Quality Control Intensive microbiological testing is a core pillar of our safety program.
- Sterility Testing (USP <71>): We conduct 14-day incubations to guarantee the complete absence of aerobic and anaerobic bacteria, as well as fungi.
- Endotoxin Testing (USP <85>): Using the Limulus Amebocyte Lysate (LAL) test, we confirm all products are non-pyrogenic and safe for injection.
- Growth Promotion: Every batch of testing media is verified to eliminate the risk of false-negative results.
5. Data-Driven Stability and Expiration Dating We do not use default dating. Beyond Use Dates (BUD) and expiration profiles are established through rigorous scientific study.
- Stability Indicating Assays: Products are tested at specific intervals under varying conditions to determine their true shelf life.
- Container Closure Integrity (CCI): Vacuum and seal integrity testing ensure the sterile seal remains completely intact through the product's expiration.
6. Environmental Monitoring and Trend Analysis Our QC department maintains continuous analytical oversight of our cleanroom environments.
- Proactive Trending: Environmental data is reviewed monthly to identify and correct shifts before they reach action levels.
- Organism Identification: If a microbe is detected, genus and species identification is performed to pinpoint the source and prevent recurrence.
7. Rigorous Analytical Method Validation We validate every test method for each specific drug formulation. This guarantees that a drug’s unique chemistry does not interfere with our ability to detect microbial contamination or potency variances.
8. Retain Sample Management We maintain a comprehensive, climate-controlled retain library. By storing representative samples from every batch, we ensure full accountability and the ability to perform retrospective testing at any point during a product's shelf life.
The MayMag Quality Balance: QC vs. QA
Our dual-layered system ensures total accountability through a strict separation of duties:
- The QC Team (Execution): Responsible for executing the scientific protocols—sampling, running HPLC diagnostics, and generating raw laboratory data.
- The QA Team (Oversight): Acting as the final safeguard, this independent team reviews QC lab reports, verifies staff training, and provides the final authorization required to release a batch for shipment.
To establish a Professional Partnership:
Contact MayMag Biologics (Formerly Tirzepatide Pharma / Zeptide Pharma)
Partner with a premier USA-based, FDA-registered 503B/506E CDMO and IND facility. As a leading sterile API manufacturer and large-scale industrial supplier, we provide comprehensive manufacturing solutions for a wide range of critical care and specialized therapeutics, including:
- Diabetic Care & Biosimilars: Insulin 70/30 pens, glargine, and advanced biosimilars.
- Injectables & Auto-Pens: Auto-injector medications and epinephrine delivery systems.
- Specialized Treatments: Weight-loss therapies, nasal sprays, and ophthalmic products.
- Essential Preparations: Sterile and bacteriostatic waters.
